Total Company Value: Revelation Biosciences Corp (REVB)
Revelation Biosciences (REVB) is a biotech startup developing immunity correction methods whose financial stability depends on clinical trial outcomes. Efficient supply chain management and raw material temperature control help maintain high profitability. However, funding shortages and R&D expenses force the company to raise capital through secondary offerings. The market dynamics reflected in the quotes show an Enterprise Value of -8.62.
&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_REVB_-_Revelation-Biosciences_-_Enterprise-Value "REVB Revelation Biosciences, Inc.: Total Company Value in the range 11/23/2025 - 10/28/2026 | 👁️GURU.Markets👁️")
Revelation Biosciences (REVB) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:Revelation Biosciences Inc (REVB)
The Revelation Biosciences (REVB) model relies on long-term market monopolization through immunostimulant patents that create a stable cash flow. By analyzing the historical enterprise value trend, an investor can identify the business's actual price tag, calculated as the sum of market capitalization and net debt, which allows for an assessment of the current acquisition cost considering the company's liquidity.
Competitor analysis for Revelation Biosciences
ARGX - Total Enterprise Value|BNTX - Real Price to Acquire Entire Company|ABVX - Total Company Value|ADMA Biologics (ADMA) - Enterprise Value|PTGX (protagonist-inc.com) - Total Company Value|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com (TRML)|Precigen (PGEN) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Pharming Group NV (PHAR)|Enterprise Value NKTR|Upstream Pharma - Company Buyout Price|ZBIO: Total Company Value|IMNM: Real Price to Acquire Entire Company|GOSS (Gossamer Bio) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|SEPN (Septerna Corp) - Real Price to Acquire Entire Company|Enterprise Value PVLA|Total Company Value Savara Inc. SVRA|Business Value rigel.com (RIGL)|ANAB: Enterprise Value|Astria Therapeutics Inc - Total Enterprise Value|Total Company Value enGene Bio (ENGN)|RAPT - Value Adjusted for Debt and Cash|Enterprise Value JBIO|Total Enterprise Value aclaristx.com|Real Price to Acquire Entire Company Kyverna Therapeutics, Inc.|Total Company Value Tiziana Life Sciences Ltd.|Cabaletta Bio, Inc - Enterprise Value|Total Enterprise Value VTYX (Ventyx Biosciences, Inc)|Total Company Value Theratechnologies Inc. THTX|Total Company Value avalotx.com AVTX|Eledon Pharmaceuticals, Inc. - Enterprise Value|Agenus, Inc. (AGEN) - Enterprise Value|CLYM - Real Price to Acquire Entire Company|Zura Bio Ltd (ZURA) - Aggregate Business Value|ATYR: Enterprise Value|Company Buyout Price ADAG|ImageneBio Inc - Total Company Value|Total Enterprise Value STTK (shattucklabs.com)|EQ - Total Company Value|CNTB - Business Value|Real Price to Acquire Entire Company Immunic Inc (IMUX)|ATRA - Value Adjusted for Debt and Cash|inflarx.de (IFRX) - Enterprise Value|X4 Pharmaceuticals Inc. (XFOR) - Total Company Value|ACET: Enterprise Value|Company Buyout Price CELU|INmune Bio, Inc. - Total Company Value|Total Enterprise Value BRNS (barinthusbio.com)|Total Company Value KZR|Company Buyout Price SAB Biotherapeutics Inc. SABS|AKTX: Enterprise Value|ENLV - Real Price to Acquire Entire Company|q32bio.com - Enterprise Value|geovax.com (GOVX) - Company Buyout Price|Enterprise Value EDSA (Edesa Biotech)|Total Enterprise Value IBIO|Total Company Value Carisma Therapeutics CARM|Business Value XTL Bio (XTLB)|Bolt Biotherapeutics, Inc. - Enterprise Value|Real Price to Acquire Entire Company HCW Biologics, Inc. HCWB|APVO (Aptevo) - Enterprise Value|AIM: Total Enterprise Value|aditxt.com - Total Company Value|GRI (GRI Bio Corporation) - Company Buyout Price|XRTX - Total Company Value|Value Adjusted for Debt and Cash reshapelifesciences.com|Indaptus Therapeutics, Inc. - Enterprise Value|Total Enterprise Value Scinai Immunotherapeutics Ltd SCNI|Real Price to Acquire Entire Company CalciMedica CALI|Total Company Value Affimed NV AFMD|ALLK - Enterprise Value|HOOK: Total Company Value|Total Company Value igmbio.com (IGMS)|iTeos Therapeutics Inc (ITOS) - Full Business Value|OCEA - Enterprise Value|Value Adjusted for Debt and Cash TC BioPharm Ltd|Enterprise Value THRD